PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedicine, Aarhus Research Center for Innate Immunology, Aarhus University, Aarhus, Denmark. olagnier@biomed.au.dk.\', \'Department of Biomedicine, Aarhus Research Center for Innate Immunology, Aarhus University, Aarhus, Denmark.\', \'Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.\', \'Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid), Nicolás Cabrera 1, 28049, Madrid, Spain.\', \'Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.\', \'Omiics ApS, Åbogade 15, 8200, Aarhus N, Denmark.\', \'Children\'s Hospital of Eastern Ontario Research Institute, Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ottawa, ON, K1H 8L1, Canada.\', \'Department of Chemistry, Aarhus University, Aarhus, Denmark.\', \'Fox Chase Cancer Center, 333 Cottman Avenue, Philidelphia, PA, 19111-2497, USA.\', \'Lars Bolund Institute of Regenerative Medicine, BGI-Shenzhen, Shenzhen, 518083, China.\', \'Department of Biology, University of Copenhagen, 2100, Copenhagen, Denmark.\', \'Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, 37075, Göttingen, Germany.\', \'Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy.\', \'Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.\', \'Department of Biomedicine, Aarhus Research Center for Innate Immunology, Aarhus University, Aarhus, Denmark. holm@biomed.au.dk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-020-18764-3
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33009401
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all